Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2008-03, Vol.22 (3), p.668-669
Hauptverfasser:	Andersen, R S, Wenandy, L, Sørensen, R B, thor Straten, P, Andersen, M H
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Antigen Presentation Apoptosis Cancer Research Cancer vaccines Cancer Vaccines - immunology Carcinoma - blood Carcinoma - immunology Care and treatment Chronic myeloid leukemia Critical Care Medicine Cytotoxicity, Immunologic Dendritic Cells - immunology Epitopes Epitopes - immunology Genetic aspects Health aspects Hematology Histocompatibility antigen HLA HLA-A2 Antigen - immunology Humans Immunotherapy Intensive Internal Medicine Kidney Neoplasms - blood Kidney Neoplasms - immunology letter-to-the-editor Leukemia, Myeloid - immunology Leukemia, Myeloid - pathology Major histocompatibility complex Mcl-1 protein Medicine Medicine & Public Health Myeloid Cell Leukemia Sequence 1 Protein Neoplasm Proteins - immunology Neoplasms - immunology Neoplasms - therapy Oncology Peptide Fragments - chemical synthesis Peptide Fragments - immunology Proto-Oncogene Proteins c-bcl-2 - immunology T-Cell Antigen Receptor Specificity T-Lymphocytes, Cytotoxic - immunology Tumor Escape - immunology Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!